TickerKhojHDFC Mutual Fund · Equity · Sectoral / Thematic · Regular plan
HDFC Pharma and Healthcare Fund - Regular Plan - Growth
₹21.264NAV on 2 Nov 2026Expense ratio 2.12%
3 Nov 2025NAV low 16.36 · high 22.1+21.1%
In plain words
Over 3 years it returned +28.9% a year, against +7.4% for its benchmark index.
Its worst fall from a peak in the last 3 years was -15.1%.
On 3-year return it ranks 3 of 139 funds in Sectoral / Thematic.
A monthly SIP over 3 years ended ₹9,885 higher in the direct plan than the regular plan, because of the lower expense ratio.
Past returns, not a promise of future returns or a recommendation.
Returns vs benchmark
| Period | Fund | Benchmark |
|---|---|---|
| 1 month | +0.2% | +1.9% |
| 3 months | +0.9% | -5.1% |
| 6 months | +16.6% | -3.2% |
| 1 year | +22.8% | -10.2% |
| 3 years (yearly) | +28.9% | +7.4% |
| Since start (yearly) | +27.9% | +11.2% |
Monthly SIP of ₹10,000
| Period | Invested | Value now | Yearly return |
|---|---|---|---|
| 1 year | ₹1,20,000 | ₹1,37,086 | +27.2% |
| 3 years | ₹3,60,000 | ₹4,96,407 | +22.0% |
Other plan of this fund: HDFC Pharma and Healthcare Fund - Direct Plan - Growth